Profile: Cephalon, Inc. is a biopharmaceutical company. We specialize in drugs to treat and manage neurological diseases, sleep disorders, cancer & pain. We offer products like NUVIGILr, TREANDAr, FENTORAr & FENTORAr. TRISENOXr injection is a highly effective therapy for first and subsequent relapse in acute promyelocytic leukemia (APL). It is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR. Our provigil is originally approved for the treatment of excessive daytime sleepiness associated with narcolepsy. Our actiq is the only prescription medicine approved in the world for treatment of breakthrough pain in opioid-tolerant cancer patients.